HealthMore in Health→
Biotech Investors Are Starting to Chase New Bets Again
After spending years concentrating on existing portfolios, biotech venture capital firms are beginning to fund new opportunities again, signaling a cautious return to risk in the sector.
Key Takeaways
- Biotech VCs are showing more appetite for new deals.
- The shift follows years of focusing on existing portfolios.
DE
DT Editorial Team··via endpoints.news